Sex and Cardiovascular Involvement in Inflammatory Joint Diseases

被引:12
作者
Castaneda, Santos [1 ,2 ]
Gonzalez-Juanatey, Carlos [3 ]
Gonzalez-Gay, Miguel A. [4 ]
机构
[1] Hosp La Princesa, Rheumatol Div, IIS Princesa, C Diego de Leon 62, Madrid 28006, Spain
[2] UAM, Madrid, Spain
[3] Hosp Lucus Augusti, Div Cardiol, C Dr Ulises Romero 1, Lugo 27003, Spain
[4] Univ Cantabria, Epidemiol Genet & Atherosclerosis Res Grp Syst In, Hosp Univ Marques Valdecilla, IDIVAL,Rheumatol Div, Avda Valdecilla S-N, Santander 39008, Spain
关键词
Cardiovascular morbidity; Gender; Heart disease; Rheumatoid arthritis; Ankylosing spondylitis; Psoriatic arthritis; RHEUMATOID-ARTHRITIS PATIENTS; ISCHEMIC-HEART-DISEASE; GENDER-RELATED DIFFERENCES; C-REACTIVE PROTEIN; P-WAVE DISPERSION; PSORIATIC-ARTHRITIS; ANKYLOSING-SPONDYLITIS; RISK-FACTORS; DIASTOLIC DYSFUNCTION; VENOUS THROMBOEMBOLISM;
D O I
10.1007/s12016-017-8635-2
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
The term inflammatory joint disease (IJD) encompasses a group of chronic conditions with predominant joint involvement. They share an increased risk of cardiovascular (CV) complications. However, the implication of the sex in the risk of CV disease in IJD has not been specifically addressed. The aim of this work is to assess the influence of sex on the clinical expression of CV manifestations associated to IJD. With this objective, an update of the current knowledge of the sex influence on CV disease in patients with IJD was conducted. A PubMed database search of the most relevant literature on this topic was performed mainly based on studies published in English over the last 10years. Although most studies on IJD were not specifically designed to address sex differences regarding CV complications, it seems that men with rheumatoid arthritis (RA) are at higher risk of pericarditis, ischemic heart disease, heart failure (HF) with reduced ejection fraction (EF), and CV mortality than women with RA. In contrast, HF with preserved EF and diastolic dysfunction is more frequent in women with RA. Men with ankylosing spondylitis present more frequently disorders of the conduction system and aortic valvulopathy than women. A limited number of studies addressed CV differences according to sex in psoriatic arthritis. Although there are some differences according to sex in the clinical expression of CV complications in patients with IJD, much research is still needed to better identify the implication of sex in the risk of CV disease in these patients.
引用
收藏
页码:278 / 292
页数:15
相关论文
共 50 条
  • [41] Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project
    Castaneda, Santos
    Martin-Martinez, Maria A.
    Gonzalez-Juanatey, Carlos
    Llorca, Javier
    Garcia-Yebenes, Maria J.
    Perez-Vicente, Sabina
    Sanchez-Costa, Jesus T.
    Diaz-Gonzalez, Federico
    Gonzalez-Gay, Miguel A.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 44 (06) : 618 - 626
  • [42] Inflammatory arthritis as a novel risk factor for cardiovascular disease
    John, Holly
    Kitas, George
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2012, 23 (07) : 575 - 579
  • [43] Risk factors of cardiovascular complications in inflammatory seronegative spondyloarthropathies
    Ozdowska, Patrycja
    Dabrowski, Rafal
    Gluszko, Piotr
    Szwed, Hanna
    KARDIOLOGIA POLSKA, 2013, 71 (04) : 417 - 420
  • [44] Cardiovascular Involvement in Autoimmune Diseases
    Amaya-Amaya, Jenny
    Montoya-Sanchez, Laura
    Rojas-Villarraga, Adriana
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [45] Pharmacodynamic Monitoring of Biological Therapies in Chronic Inflammatory Diseases
    Dreesen, Erwin
    Gils, Ann
    THERAPEUTIC DRUG MONITORING, 2019, 41 (02) : 131 - 141
  • [46] The Importance of Outcome Measures in the Management of Inflammatory Rheumatic Diseases
    Collada, Juan Molina
    Trives, Laura
    Castrejon, Isabel
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2021, 13 : 191 - 200
  • [47] In-label treatment of inflammatory joint diseases
    Kneitz, C.
    Fiehn, C.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2018, 77 (07): : 559 - 568
  • [48] Effect of Intensive Lipid-Lowering Therapy on Cardiovascular Outcome in Patients With and Those Without Inflammatory Joint Disease
    Semb, Anne Grete
    Kvien, Tore K.
    DeMicco, David A.
    Fayyad, Rana
    Wun, Chuan-Chuan
    LaRosa, John C.
    Betteridge, John
    Pedersen, Terje R.
    Holme, Ingar
    ARTHRITIS AND RHEUMATISM, 2012, 64 (09): : 2836 - 2846
  • [49] SAFETY OF BIOLOGICAL TREATMENT IN A BULGARIAN POPULATION OF PATIENTS WITH INFLAMMATORY JOINT DISEASES: RETROSPECTIVE STUDY OF ADVERSE DRUG REACTIONS
    Parvova, Iva
    Hristov, Emil
    Rashkov, Rasho
    Getov, Ilko
    Ognianov, Sava
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2019, 72 (10): : 1409 - 1418
  • [50] Impact of persistence with tumour necrosis factor inhibitors on healthcare resource utilization and costs in chronic inflammatory joint diseases
    Belhassen, Manon
    Tubach, Florence
    Hudry, Christophe
    Woronoff-Lemsi, Macha
    Levy-Bachelot, Laurie
    Van Ganse, Eric
    Fautrel, Bruno
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (01) : 163 - 177